- Research works
- 40 ▲ 813% vs 2013–17
- Citations
- 579 14.5 per fractional work
- Top-10% rate
- 8.6% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Oncopeptides (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.4×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.4×
- Pharmacology, Toxicology and Pharmaceutics 4.7×
- Medicine 2.9×
- Chemistry 1.6×
- Mathematics 1.1×
- Environmental Science 0.6×
- Computer Science 0.6×
- Economics, Econometrics and Finance 0.6×
- Immunology and Microbiology 0.3×
- Neuroscience 0.3×
- Materials Science 0.1×
- Health Professions 0.1×
Who are the top researchers at Oncopeptides (Sweden)?
Ranked on the composite score, Fredrik Lehmann lead among researchers whose main affiliation is Oncopeptides (Sweden).
- 1 Fredrik Lehmann Sweden · #1,505,474 worldwide 20 citations · 22 works
Which keywords describe research at Oncopeptides (Sweden)?
By fractional works in all years, weighted toward what it does more of than the world: Proteasome Inhibitors, Diagnosis Criteria, International Myeloma Working Group, Cancer Therapy, Angiogenesis, Tumor Microenvironment, PET Imaging and Fibroblast Activation Protein.
- Growth Hormone
- Autism Spectrum Disorders
- Pharmacology
- Chemotherapy
- Chemotherapy-Induced Peripheral Neuropathy
- Quality of Life
- Glycosylation
- Tumor Suppression
- Mutation
- Protein-Protein Interactions
- Metabolism
- Drug Discovery
- PROTACs
- Transcriptional Regulation
- Fibroblast Activation Protein
- PET Imaging
- Cancer Therapy
- Diagnosis Criteria
- Proteasome Inhibitors
- International Myeloma Working Group
- Angiogenesis
- Tumor Microenvironment
- Immunosuppression
- BET Bromodomains
- Cancer
- Apoptosis
- Medicinal Chemistry
- Foldamers
- Peptide Synthesis
- Cell Cycle
- Metastatic Breast Cancer
- p53
- Taxanes
- Monoclonal Antibodies
- Therapeutic Antibodies
- Feeding Problems
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 36 words, with their numbers
- Proteasome Inhibitors8▲ 295×2 topics
- Diagnosis Criteria7▲ 614×1 topic
- International Myeloma Working Group7▲ 614×1 topic
- Cancer Therapy7▲ 26×8 topics
- Angiogenesis4▲ 25×5 topics
- PET Imaging4▲ 41×2 topics
- Tumor Microenvironment4▲ 25×2 topics
- Fibroblast Activation Protein3▲ 166×1 topic
- Immunosuppression3▲ 73×1 topic
- Transcriptional Regulation3▲ 33×3 topics
- BET Bromodomains3▲ 380×1 topic
- PROTACs3▲ 380×1 topic
- Cancer3▲ 4.8×6 topics
- Drug Discovery2▲ 15×5 topics
- Apoptosis2▲ 11×5 topics
- Metabolism2▲ 6.5×2 topics
- Medicinal Chemistry2▲ 10×6 topics
- Protein-Protein Interactions2▲ 35×2 topics
- Foldamers1▲ 43×1 topic
- Mutation1▲ 22×2 topics
- Peptide Synthesis1▲ 43×1 topic
- Tumor Suppression1▲ 30×2 topics
- Cell Cycle1▲ 57×1 topic
- Glycosylation1▲ 15×3 topics
- Metastatic Breast Cancer1▲ 48×2 topics
- Quality of Life1▲ 2.4×2 topics
- p531▲ 76×1 topic
- Chemotherapy-Induced Peripheral Neuropathy1▲ 62×1 topic
- Taxanes1▲ 62×1 topic
- Chemotherapy1▲ 3.8×8 topics
- Monoclonal Antibodies1▲ 19×2 topics
- Pharmacology1▲ 8.2×3 topics
- Therapeutic Antibodies1▲ 22×2 topics
- Autism Spectrum Disorders1▲ 29×1 topic
- Feeding Problems1▲ 73×1 topic
- Growth Hormone1▲ 31×2 topics
Which research topics does Oncopeptides (Sweden) publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Cancer-related Molecular Pathways, Protein Degradation and Inhibitors and PI3K/AKT/mTOR signaling in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 4 works
- 2 Cancer-related Molecular Pathways Oncology 1 works
- 3 Protein Degradation and Inhibitors Molecular Biology 1 works
- 4 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 6 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 0 works
- 7 Chemical Synthesis and Analysis Molecular Biology 0 works
- 8 Cancer Treatment and Pharmacology Oncology 0 works
- 9 Chemistry and Chemical Engineering Environmental Chemistry 0 works
- 10 Peptidase Inhibition and Analysis Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Oncopeptides (Sweden)'s research output changed?
Output in 2018–2022 was 813% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Stockholm
- Karolinska Institutet
- KTH Royal Institute of Technology
- Stockholm University
- Karolinska University Hospital
- Swedish Institute
- Stockholm School of Economics
- Science for Life Laboratory
- Swedish Defence Research Agency
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.